APA (7th ed.) Citation

M, E., JD, R., J, Y., SW, B., CE, D., & BD, W. (2021). Tolerance of dinutuximab therapy for treatment of high-risk neuroblastoma in two patients with end-stage renal disease on dialysis. Pediatric blood & cancer, 68(3), e28852. https://doi.org/10.1002/pbc.28852

Chicago Style (17th ed.) Citation

M, Emberesh, Rubinstein JD, Young J, Benoit SW, Dandoy CE, and Weiss BD. "Tolerance of Dinutuximab Therapy for Treatment of High-risk Neuroblastoma in Two Patients with End-stage Renal Disease on Dialysis." Pediatric Blood & Cancer 68, no. 3 (2021): e28852. https://doi.org/10.1002/pbc.28852.

MLA (9th ed.) Citation

M, Emberesh, et al. "Tolerance of Dinutuximab Therapy for Treatment of High-risk Neuroblastoma in Two Patients with End-stage Renal Disease on Dialysis." Pediatric Blood & Cancer, vol. 68, no. 3, 2021, p. e28852, https://doi.org/10.1002/pbc.28852.